Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Amalfitano

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Gene Therapy|October 12, 1999
Next-generation adenoviral vectors: new and improvedA Amalfitano
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|October 6, 2007
Progress and problems when considering gene therapy for GSD-IIA Kiang, A Amalfitano
Molecular Medicine Today|June 7, 2000
Towards a molecular therapy for glycogen storage disease type II (Pompe disease)Y T Chen, A Amalfitano
Muscle & Nerve|December 1, 1996
The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx alleleA Amalfitano, J S Chamberlain
Gene Therapy|March 1, 1997
Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapyA Amalfitano, J S Chamberlain
Human Gene Therapy|February 27, 1999
Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent miceH Hu, D Serra, A Amalfitano
Molecular and Cellular Biology|August 1, 1992
Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouseA Amalfitano, L G Martin, M M Fluck
Journal of Virology|August 10, 1999
Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymeraseD Hartigan-O'Connor, A Amalfitano, J S Chamberlain
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectorsA Amalfitano, C R Begy, J S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodiesH Jiang, Z Wang, D Serra, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Gene Therapy|October 12, 1999
Next-generation adenoviral vectors: new and improvedA Amalfitano
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|October 6, 2007
Progress and problems when considering gene therapy for GSD-IIA Kiang, A Amalfitano
Molecular Medicine Today|June 7, 2000
Towards a molecular therapy for glycogen storage disease type II (Pompe disease)Y T Chen, A Amalfitano
Muscle & Nerve|December 1, 1996
The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx alleleA Amalfitano, J S Chamberlain
Gene Therapy|March 1, 1997
Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapyA Amalfitano, J S Chamberlain
Human Gene Therapy|February 27, 1999
Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent miceH Hu, D Serra, A Amalfitano
Molecular and Cellular Biology|August 1, 1992
Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouseA Amalfitano, L G Martin, M M Fluck
Journal of Virology|August 10, 1999
Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymeraseD Hartigan-O'Connor, A Amalfitano, J S Chamberlain
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectorsA Amalfitano, C R Begy, J S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodiesH Jiang, Z Wang, D Serra, et al.
Pageof 4